Efficacy of Photon-Counting Detector CT Iodine Mapping for Detecting Myocardial Late Enhancement

Overview

This study evaluated the diagnostic accuracy of iodine maps from photon-counting detector CT (PCD-CT) in detecting myocardial late iodine enhancement (LIE) compared to late gadolinium enhancement (LGE) cardiac MRI. The results demonstrate that PCD-CT iodine mapping shows promise as a non-invasive alternative for myocardial tissue characterization with comparable detection of myocardial fibrosis and scar.

Background

Late gadolinium enhancement (LGE) cardiac MRI is the established reference for detecting myocardial fibrosis and scar in various cardiac conditions, including cardiomyopathies, myocardial infarction, and myocarditis. However, MRI has limitations such as long scan times, susceptibility to artifacts, contraindications in patients with certain implants, and challenges in claustrophobic patients. Cardiac CT, particularly with photon-counting detector technology, offers improved spatial resolution, noise reduction, and spectral imaging capabilities, enabling iodine quantification maps that may mimic LGE MRI. This study investigates the diagnostic accuracy of PCD-CT iodine maps for myocardial late enhancement detection compared to LGE MRI.

Data Highlights

The study included consecutive patients undergoing cardiac MRI followed by same-day PCD-CT scans. LGE MRI was performed 10–12 minutes after gadobutrol administration, serving as the reference standard. PCD-CT scans included delayed phase imaging 5 minutes post iodinated contrast administration, with iodine maps reconstructed at 1.0 mm slice thickness. Two blinded radiologists independently assessed image quality and enhancement detection. Subjective image quality was rated on 4-point scales for noise, sharpness, and overall quality. Objective image quality was assessed by region-of-interest measurements in the myocardium.

Key Findings

• PCD-CT iodine maps demonstrated improved spatial resolution and spectral capabilities compared to conventional CT, enabling detailed myocardial tissue characterization.
• Iodine maps effectively suppressed surrounding soft tissues, highlighting contrast-enhanced myocardial regions analogous to LGE MRI nulling techniques.
• Diagnostic accuracy of PCD-CT iodine mapping for detecting myocardial late enhancement was comparable to LGE MRI, supporting its potential as an alternative imaging modality.
• Subjective image quality assessments showed minimal noise and excellent sharpness on iodine maps, facilitating confident interpretation.
• Objective measurements confirmed reliable iodine quantification within myocardial regions, correlating with extracellular volume expansion seen in fibrosis and scar.

Clinical Implications

PCD-CT iodine mapping offers a promising alternative to LGE MRI for myocardial fibrosis and scar detection, especially in patients contraindicated for MRI or with limited MRI tolerance. The improved image quality and spectral imaging capabilities of PCD-CT may enhance diagnostic confidence and enable broader clinical application of myocardial tissue characterization. This technique could streamline cardiac imaging workflows by combining coronary assessment and myocardial characterization in a single CT examination.

Conclusion

Photon-counting detector CT iodine mapping provides accurate detection of myocardial late enhancement comparable to the established LGE MRI standard. This technology holds potential to expand non-invasive cardiac tissue characterization options in clinical practice.

References

1. Various Authors/Multiple Years -- Clinical guidelines and studies on LGE MRI and cardiac CT
2. Siemens Healthineers/2021-2022 -- Photon-counting detector CT technology and cardiac imaging protocols